Showing results (1261-1270 of 2,960) with videos related to

Sort By:
Pageof 296
Cancer Chemotherapy and Pharmacology|June 2, 2011
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombinationMichele Tavecchio, Joanne M Munck, Celine Cano, et al.
BMC Medical Genetics|December 7, 2010
Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructorKaren Curtin, Roger K Wolff, Jennifer S Herrick, et al.
Brain Injury|February 2, 2011
Outcomes of participation objective, participation subjective (POPS) measure following traumatic brain injuryMichael Curtin, Jennifer Jones, Graham A Tyson, et al.
Nature Materials|August 3, 2010
Quantitative prediction of solute strengthening in aluminium alloysGerard Paul M Leyson, William A Curtin, Louis G Hector, et al.
AMB Express|November 3, 2011
Effects of rehydration nutrients on H2S metabolism and formation of volatile sulfur compounds by the wine yeast VL3Gal Winter, Paul A Henschke, Vincent J Higgins, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 26, 2004
Short-term in vitro and in vivo analyses for assessing the tumor-promoting potentials of cigarette smoke condensatesGeoffrey M Curtin, Margaret Hanausek, Zbigniew Walaszek, et al.
Oncogene|August 3, 2004
Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repairStephany J Veuger, Nicola J Curtin, Graeme C M Smith, et al.
European Journal of Gynaecological Oncology|January 1, 1994
Image analysis of the distribution of intraperitoneally administered fluids in patients with ovarian cancerC Levenback, J Curtin, D Johnston, et al.
Gynecologic Oncology|November 1, 1994
Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic featuresR R Barakat, G Wong, J P Curtin, et al.
Thrombosis Research|October 1, 2014
Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: a multicentre, retrospective studyJeremy D Robertson, Pauline Higgins, Jamie Price, et al.
Pageof 296